Return to content in this issue

Effectiveness of Biologics in Patients With Severe Asthma and Psychiatric Comorbidities

Mascaró-Hereza B^1,2, Loli-Ausejo D^1,2, Valero A^1,2,3, Arismendi E^3,4, Bobolea I<sup>1,2,3

1</sup>Department of Allergy, Hospital Clínic, Barcelona, Spain
²IDIBAPS Clinical and Experimental Respiratory Immunology (IRCE), August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
³CIBER of Respiratory Diseases (CIBERES), Health Institute Carlos III
⁴Department of Pulmonology, Hospital Clínic, Barcelona, Spain

J Investig Allergol Clin Immunol 2025; Vol 35(2) : 147-148
doi: 10.18176/jiaci.1034

• Abstract
• Supplemental Materials

Key words: Severe asthma, Biologics, Monoclonal antibodies, Treatment, Comorbidities

	Title	Type	Size
	doi10.18176_jiaci.1034_supplemental-materials-table_1.pdf	pdf	150.16 Kb